Where is Oligoscan located?

Oligoscan is headquartered in France.

Is Oligoscan a funded company?

Oligoscan is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Oligoscan rank among its competitors?

Oligoscan ranks 5th amongst 4 active competitors, none of which are funded.

Who are the top competitors of Oligoscan?

Oligoscan's top competitors include Magellan Diagnostics, Baseline Health and JT MeSh Diagnostics. Among them, JT MeSh Diagnostics secured the most recent funding round in September, 2019.

Oligoscan - 2026 Company Profile & Competitors

Oligoscan is an unfunded company based in France, founded in 2010. It operates as a Developer of diagnostic device for the screening of physiological imbalances. Oligoscan has not raised any funding yet. The company has 4 active competitors, including 1 that has exited. Its top competitors include companies like Magellan Diagnostics, Baseline Health and JT MeSh Diagnostics.

Key Metrics

Founded Year

2010

Location

France

Stage

Unfunded

Ranked

5^th among 6 competitors

Similar Companies

Magellan Diagnostics & 4 more

View Oligoscan's full profile

Oligoscan has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Oligoscan include Magellan Diagnostics, Baseline Health and JT MeSh Diagnostics. Here is the list of Top 10 competitors of Oligoscan, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Magellan Diagnostics 1968, Billerica (United States), Acquired	Blood lead testing solutions to identify and protect those at risk	$34M	Abingworth, KBL & 8 others	43/100
2nd	Baseline Health 2018, San Francisco (United States), Deadpooled	Provider of test kit for diagnosing body toxins	-	-	24/100
3rd	JT MeSh Diagnostics 2019, Philadelphia (United States), Funding Raised	Developer of breakthrough diagnostics for radiation exposure and organ transplant viability	-	HHS	22/100
4th	ToxTest 2011, Esslingen Am Neckar (Germany), Unfunded	Provider of a diagnostic test for heavy metal toxicity	-	-	16/100
5th	Oligoscan 2010, France, Unfunded	Developer of diagnostic device for the screening of physiological imbalances	-	-	16/100
6th	Beaufort Bar 2012, Burlington (United States), Deadpooled	Diagnostic tests for lead poisoning	-	-	15/100